Haemorheology and cerebrovascular disease: multifunctional approach with pentoxifylline

Reference

• Ambrus J. L., Ambrus C. M., Gastpar H. Studies on platelet aggregation with pentoxifylline. Effect in neoplastic disorders and other new indications. J. Med. 1979; 10: 3391. Ambrus J. L., Ambrus C. M., Gastpar H. Studies on platelet aggregation with pentoxifylline. Effect in neoplastic disorders and other new indications. J. Med. 1979; 10: 339
   PubMedGoogle Scholar
• Angelkort B. Thrombozytenfunktion, plasmatische Blutgerinnung und Fibrinolyse bei chronisch arterieller Verschluŝkrankheit. Med. Welt 1979; 30: 12392. Angelkort B. Thrombozytenfunktion, plasmatische Blutgerinnung und Fibrinolyse bei chronisch arterieller Verschluŝkrankheit. Med. Welt 1979; 30: 1239
   PubMedGoogle Scholar
• Angelkort B., Maurin N., Boateng K. Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease. Curr. Med. Res. Opin. 1979; 6: 2553. Angelkort B., Maurin N., Boateng K. Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease. Curr. Med. Res. Opin. 1979; 6: 255
   PubMed Web of Science ®Google Scholar
• Araki G., Tokomo E. Clinical efficacy of pentoxifylline (BL 191) and pyrithioxine hydrochloride (PTX) in treatment of cerebrovascular disorders. Clin. Evaluation 1976; 4: 2134. Araki G., Tokomo E. Clinical efficacy of pentoxifylline (BL 191) and pyrithioxine hydrochloride (PTX) in treatment of cerebrovascular disorders. Clin. Evaluation 1976; 4: 213
   Google Scholar
• Blanquet P. Radiocirculographies isotopiques cerebrales chez (homme: dossier d'expertise. Quoted by Marcel, G. A., (1977). Med. Act. 1972; 4: 1015. Blanquet P. Radiocirculographies isotopiques cerebrales chez (homme: dossier d'expertise. Quoted by Marcel, G. A., (1977). Med. Act. 1972; 4: 101
   Google Scholar
• Blum R. E., Cohen M. M. Protection by pentoxifylline against ischemic deterioration of cerebral metabolism. Annu. Meeting Am. Acad. Neurol. Los Angeles April, 1978; 19786. Blum R. E., Cohen M. M. Protection by pentoxifylline against ischemic deterioration of cerebral metabolism. Annu. Meeting Am. Acad. Neurol. Los Angeles April, 1978; 1978
   Google Scholar
• Boisseau M. R., Lorient M. F., Bricaud H. Red cell deformability and risk factors in one hundred patients with cerebrovascular thrombosis. Thromb. Haemost. 1979; 42: 1077. Boisseau M. R., Lorient M. F., Bricaud H. Red cell deformability and risk factors in one hundred patients with cerebrovascular thrombosis. Thromb. Haemost. 1979; 42: 107
   Google Scholar
• Braasch D. Red cell deformability and capillary blood flow. Physiol. Rev. 1971; 51: 6798. Braasch D. Red cell deformability and capillary blood flow. Physiol. Rev. 1971; 51: 679
   Web of Science ®Google Scholar
• Brevetti G., Abate S., Lavecchia G., Ferulano G., Paudice G., Acunco R. La pentossifillina nel trattamento delle arteriopatie obliteranti al secondo stadio. Prog. Med. Rom. 1979; 35: 3639. Brevetti G., Abate S., Lavecchia G., Ferulano G., Paudice G., Acunco R. La pentossifillina nel trattamento delle arteriopatie obliteranti al secondo stadio. Prog. Med. Rom. 1979; 35: 363
   Google Scholar
• Buckert D., Harwart D. Trials of 3, 7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191) in double-blind test. Farmaco 1976; 31: 26410. Buckert D., Harwart D. Trials of 3, 7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191) in double-blind test. Farmaco 1976; 31: 264
   Google Scholar
• Cardinali D. P. Effects of pentoxifylline and aminophylline on biogenic amine metabolism of the rat brain. Eur. J. Pharmacol. 1978; 47: 23911. Cardinali D. P. Effects of pentoxifylline and aminophylline on biogenic amine metabolism of the rat brain. Eur. J. Pharmacol. 1978; 47: 239
   PubMed Web of Science ®Google Scholar
• Chmiel H., Anadere J., Heimburg P. The influence of pentoxifylline on visco-elasticity of blood in patients with peripheral vascular disorders. Capri Conf. Blood Rheology and Microcirculation. 10–11 October, 1980; 1980, Capri12. Chmiel H., Anadere J., Heimburg P. The influence of pentoxifylline on visco-elasticity of blood in patients with peripheral vascular disorders. Capri Conf. Blood Rheology and Microcirculation. 10–11 October, 1980; 1980, Capri
   Google Scholar
• Cohen M. M., Harrison H., Gray R., Becker R. The effect of pentoxifylline on cerebral ischemia and aminoacid incorporation into gerbil brain. Annu. Meeting Emer. Neurol. Assoc. St Louis, Mo 4–5 October, 1979; 197913. Cohen M. M., Harrison H., Gray R., Becker R. The effect of pentoxifylline on cerebral ischemia and aminoacid incorporation into gerbil brain. Annu. Meeting Emer. Neurol. Assoc. St LouisMo 4–5 October, 1979; 1979
   Google Scholar
• Dominguez D., De Cayaffa C. L., Gomensoro J., Aparicio J. J. Modification of psychometric, practical and intellectual parameters in patients with diffuse cerebrovascular insufficiency during prolonged treatment with pentoxifylline: a double-blind, placebo controlled trial. Pharmatherapeutica 1977; 1: 49814. Dominguez D., De Cayaffa C. L., Gomensoro J., Aparicio J. J. Modification of psychometric, practical and intellectual parameters in patients with diffuse cerebrovascular insufficiency during prolonged treatment with pentoxifylline: a double-blind, placebo controlled trial. Pharmatherapeutica 1977; 1: 498
   Google Scholar
• Ehrly A. M. Verbesserung der Flieŝeigenschaften des Blutes und der Erythrozyten bei arteriellen Verschluŝerkrankungen. Med. Welt 1975; 26: 197115. Ehrly A. M. Verbesserung der Flieŝeigenschaften des Blutes und der Erythrozyten bei arteriellen Verschluŝerkrankungen. Med. Welt 1975; 26: 1971
   PubMedGoogle Scholar
• Ehrly A. M. Rheologically induced impairment of the muscular microcirculation: A new pathophysiological concept of intermittent claudication. Proc. 9 Int. Congr. Angiol. Florence April, 1974; 197416. Ehrly A. M. Rheologically induced impairment of the muscular microcirculation: A new pathophysiological concept of intermittent claudication. Proc. 9 Int. Congr. Angiol. Florence April, 1974; 1974
   Google Scholar
• Ehrly A. M. The effect of pentoxifylline on the flow properties of hyperosmolar blood. I.R.C.S. (Med. Sci.) 1975; 3: 46517. Ehrly A. M. The effect of pentoxifylline on the flow properties of hyperosmolar blood. I.R.C.S. (Med. Sci.) 1975; 3: 465
   Google Scholar
• Ehrly A. M., Schroeder W. Oxygen pressure values in the ischemic muscle tissue of patients with chronic occlusive arterial disease. Oxygen Transport to Tissue, III, I. A. Silver, et al. Plenum, New York 1978; 40118. Ehrly A. M., Schroeder W. Oxygen pressure values in the ischemic muscle tissue of patients with chronic occlusive arterial disease. Oxygen Transport to Tissue, III, I. A. Silver, et al. Plenum, New York 1978; 401
   Google Scholar
• Feine-Haake G. Zur Objektivierung der therapeutischen Wirksamkeit von Trental 400. Fortschr. Med. 1977; 95: 4819. Feine-Haake G. Zur Objektivierung der therapeutischen Wirksamkeit von Trental 400. Fortschr. Med. 1977; 95: 48
   PubMedGoogle Scholar
• Ganser V., Boksay I. Effect of pentoxifylline on cerebral edema in cats. Neurology 1974; 24: 48720. Ganser V., Boksay I. Effect of pentoxifylline on cerebral edema in cats. Neurology 1974; 24: 487
   PubMed Web of Science ®Google Scholar
• Gastpar H. The inhibition of cancer cell stickiness by 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191). Thromb. Res. 1974; 5: 27721. Gastpar H. The inhibition of cancer cell stickiness by 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191). Thromb. Res. 1974; 5: 277
   PubMed Web of Science ®Google Scholar
• Gottstein U. Behandlung der cerebralen Mangeldurchblutung. Internist 1974; 15: 57522. Gottstein U. Behandlung der cerebralen Mangeldurchblutung. Internist 1974; 15: 575
   PubMedGoogle Scholar
• Gray S. D., Lundvall J., Millander S. Regional hyperosmolarity in relation to exercise hyperaemia. Acta Physiol. Scand. 1968; 73: 11A23. Gray S. D., Lundvall J., Millander S. Regional hyperosmolarity in relation to exercise hyperaemia. Acta Physiol. Scand. 1968; 73: 11A
   Google Scholar
• Hartmann A. Die Wirkung von Pentoxifylline auf die regionale Hirndurchblutung bei Patienten mit zerebralen Durchblutungsstdrungen Jahrestagg. Dtsch. Ges. Neurologic Wiesbaden 12–14 April, 1980; 198024. Hartmann A. Die Wirkung von Pentoxifylline auf die regionale Hirndurchblutung bei Patienten mit zerebralen Durchblutungsstdrungen Jahrestagg. Dtsch. Ges. Neurologic Wiesbaden 12–14 April, 1980; 1980
   Google Scholar
• Hartmann A. Effect of pentoxifylline on regional cerebral blood flow in patients with cerebrovascular disease. Pharmatherapeutica 1981; 2: 52825. Hartmann A. Effect of pentoxifylline on regional cerebral blood flow in patients with cerebrovascular disease. Pharmatherapeutica 1981; 2: 528
   PubMedGoogle Scholar
• Harwart D. The treatment of chronic cerebrovascular insufficiency. A double-blind study of pentoxifylline (Trental 400). Curr. Med. Res. Opin. 1979; 6: 7326. Harwart D. The treatment of chronic cerebrovascular insufficiency. A double-blind study of pentoxifylline (Trental 400). Curr. Med. Res. Opin. 1979; 6: 73
   PubMed Web of Science ®Google Scholar
• Hayashi S., Sakaguchi I., Ozawa H. Studies on 3,7-Dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191): the inhibitory effect of BL 191 on PDE in various tissues of rats. Jpn. J. Pharmacol. 1976; 26: 11727. Hayashi S., Sakaguchi I., Ozawa H. Studies on 3,7-Dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191): the inhibitory effect of BL 191 on PDE in various tissues of rats. Jpn. J. Pharmacol. 1976; 26: 117
   Google Scholar
• Heidrich H., Ott M. Vasodilatantien und Blutviskosität. Herz/Kreisl. 1974; 6: 54228. Heidrich H., Ott M. Vasodilatantien und Blutviskosität. Herz/Kreisl. 1974; 6: 542
   Google Scholar
• Heidrich H., Schlichting K., Ott M. Changes in blood viscosity due to pentoxifylline. I.R.C.S. (Med. Sci.) 1976; 4: 36829. Heidrich H., Schlichting K., Ott M. Changes in blood viscosity due to pentoxifylline. I.R.C.S. (Med. Sci.) 1976; 4: 368
   Google Scholar
• Hensel A. Effect of pentoxifylline on adenine nucleotides of human erythrocytes. 16th Int. Congr. Hematology. Kyoto Sept., 1976; 197630. Hensel A. Effect of pentoxifylline on adenine nucleotides of human erythrocytes. 16th Int. Congr. Hematology. Kyoto Sept., 1976; 1976
   Google Scholar
• Herskovits E., Vazquez A., Famulari A., Tamaroff L., Traiman H., Gonzales A. M., Smud R., Vila J., Matera V. A randomized clinical trial of pentoxifylline and anti-aggregants in recent transient ischemic attacks (TIA). A one year follow-up. Capri Conf. Blood Rheology and Microcirculation. Capri 10–11 October, 1980; 198031. Herskovits E., Vazquez A., Famulari A., Tamaroff L., Traiman H., Gonzales A. M., Smud R., Vila J., Matera V. A randomized clinical trial of pentoxifylline and anti-aggregants in recent transient ischemic attacks (TIA). A one year follow-up. Capri Conf. Blood Rheology and Microcirculation. Capri 10–11 October, 1980; 1980
   Google Scholar
• Hess H. Neue Vorstellungen zur Physiopathologie der Angiopathie. Herz/Kreisl. 1971; 3: 15532. Hess H. Neue Vorstellungen zur Physiopathologie der Angiopathie. Herz/Kreisl. 1971; 3: 155
   Google Scholar
• Hess H., Franke I., Jauch M. Medikamentöse Verbesserung der Flieŝeigenschaften des Blutes. Fortschr. Med. 1973; 91: 74333. Hess H., Franke I., Jauch M. Medikamentöse Verbesserung der Flieŝeigenschaften des Blutes. Fortschr. Med. 1973; 91: 743
   PubMedGoogle Scholar
• Iijima M. Changes in gas content of blood and CSF in C.V.D. patients — especially in those at the chronic stage of C.V.D. 3rd Gen. Meet. Jpn. Soc. Stroke. Akito, Japan 197834. Iijima M. Changes in gas content of blood and CSF in C.V.D. patients — especially in those at the chronic stage of C.V.D. 3rd Gen. Meet. Jpn. Soc. Stroke. Akito, Japan 1978
   Google Scholar
• Itoh T., Satoh T. Influence of pentoxifylline (‘Trental’) on platelet aggregation and serum lipids in patients with obstructive cerebrovascular disorders. Pharmatherapeutica 1979; 2: 15935. Itoh T., Satoh T. Influence of pentoxifylline (‘Trental’) on platelet aggregation and serum lipids in patients with obstructive cerebrovascular disorders. Pharmatherapeutica 1979; 2: 159
   Google Scholar
• Janaki S. Pentoxifylline in strokes: a clinical study. J. Int. Med. Res. 1980; 8: 5636. Janaki S. Pentoxifylline in strokes: a clinical study. J. Int. Med. Res. 1980; 8: 56
   PubMed Web of Science ®Google Scholar
• Jarrett P. E. M., Moreland M., Browse N. L. The effect of oxpentifylline on fibrinolytic activity and plasma fibrinogen levels. Curr. Med. Res. Opin. 1977; 4: 49237. Jarrett P. E. M., Moreland M., Browse N. L. The effect of oxpentifylline on fibrinolytic activity and plasma fibrinogen levels. Curr. Med. Res. Opin. 1977; 4: 492
   PubMed Web of Science ®Google Scholar
• Jovanovi U. J. Polygrapbische Registrierungen nach parenteraler Applikation von 3,7-Dimethyl-1-(5-oxo-hexyl)-xanthin (BL 191). Arzneim. Forsch. 1976; 22: 99438. Jovanovi U. J. Polygrapbische Registrierungen nach parenteraler Applikation von 3,7-Dimethyl-1-(5-oxo-hexyl)-xanthin (BL 191). Arzneim. Forsch. 1976; 22: 994
   Google Scholar
• Jovanovi U. J. Statistical evaluation of polygraphic investigations of pentoxifylline. J. Int. Med. Res. 1976; 4: 21139. Jovanovi U. J. Statistical evaluation of polygraphic investigations of pentoxifylline. J. Int. Med. Res. 1976; 4: 211
   PubMed Web of Science ®Google Scholar
• Kellner H. Zur Behandlung chronischer arterieller Durchblutungsstörungen. Doppelblindversuch mit Trental 400. Münch. Med. Wochenschr. 1976; 118: 139940. Kellner H. Zur Behandlung chronischer arterieller Durchblutungsstörungen. Doppelblindversuch mit Trental 400. Münch. Med. Wochenschr. 1976; 118: 1399
   Google Scholar
• Koller R. E. B., Cohen M. M. Effect of pentoxifylline on in vitro cerebral metabolism. Trans. Am. Soc. Neurochem. 1976; 7: 16141. Koller R. E. B., Cohen M. M. Effect of pentoxifylline on in vitro cerebral metabolism. Trans. Am. Soc. Neurochem. 1976; 7: 161
   Google Scholar
• Koppenhagen K. 1980, Personal communication42. Koppenhagen K. 1980, Personal communication
   Google Scholar
• Koppenhagen K., Wenig H. G. The effect of pentoxifylline on cerebral blood flow. Acta Neurol. Scand. 1979; 60: 626, Suppl. 7243. Koppenhagen K., Wenig H. G. The effect of pentoxifylline on cerebral blood flow. Acta Neurol. Scand. 1979; 60: 626, Suppl. 72
   Google Scholar
• Lechner H., Ott E. Klinische Bedeutung von Blutviskositätsveränderungen im Rahmen der cerebrovaskulären Insuffizienz. Münch. Med. Wochenschr. 1975; 117: 159944. Lechner H., Ott E. Klinische Bedeutung von Blutviskositätsveränderungen im Rahmen der cerebrovaskulären Insuffizienz. Münch. Med. Wochenschr. 1975; 117: 1599
   Google Scholar
• Linden L. The effect of stellate ganglion block on cerebral circulation in cerebrovascular accidents. Acta Med. Scand. 1955; 151: 30145. Linden L. The effect of stellate ganglion block on cerebral circulation in cerebrovascular accidents. Acta Med. Scand. 1955; 151: 301
   Google Scholar
• Lusov V. A., Belousov J. B., Sidelmann A. A., Savenkov M. P., Cholodova O. E., Dudaev V. A. The treatment of peripheral arteriosclerosis with pentoxifylline. Pharmatherapeutica 1978; 2: 123, Suppl. 146. Lusov V. A., Belousov J. B., Sidelmann A. A., Savenkov M. P., Cholodova O. E., Dudaev V. A. The treatment of peripheral arteriosclerosis with pentoxifylline. Pharmatherapeutica 1978; 2: 123, Suppl. 1
   Google Scholar
• Manrique R. V. Avaliacao clinico-laboratorial da modificacao da flexibilidade eriteocita ria induzida pela pentoxifilina. Rev. Bras. Clin. Ter. 1979; 8: 57247. Manrique R. V. Avaliacao clinico-laboratorial da modificacao da flexibilidade eriteocita ria induzida pela pentoxifilina. Rev. Bras. Clin. Ter. 1979; 8: 572
   Google Scholar
• Marcel G. A. Red cell deformability: physiological, clinical and pharmacological aspects. J. Med. 1979; 10: 40948. Marcel G. A. Red cell deformability: physiological, clinical and pharmacological aspects. J. Med. 1979; 10: 409
   PubMedGoogle Scholar
• Martin P. Deformabilité des globules rouges et accidents vasculaires cerebraux. Interêt de la pentoxifylline. Gaz. Med. France 1979; 86: 258549. Martin P. Deformabilité des globules rouges et accidents vasculaires cerebraux. Interêt de la pentoxifylline. Gaz. Med. France 1979; 86: 2585
   Google Scholar
• Maudonnct O. A. Q. Double-blind clinical trial with BL 191 (1-[5′-oxihexil]-3,7-dimetil-xantine) in the treatment of patients bearing a peripheric vestibular syndromes of vascular etiology. Rev. Bras. Med. 1977; 34: 9550. Maudonnct O. A. Q. Double-blind clinical trial with BL 191 (1-[5′-oxihexil]-3,7-dimetil-xantine) in the treatment of patients bearing a peripheric vestibular syndromes of vascular etiology. Rev. Bras. Med. 1977; 34: 95
   Google Scholar
• Metoki H., Kanazawa T., Shibutani K., Izawa M., Soma Y., Onodera K. A study on blood viscosity in CVA - the relationships between blood viscosity and duration after stroke, and the effects of pentoxifylline. Acta Neurol. Scand. 1979; 60: 622, Suppl. 7251. Metoki H., Kanazawa T., Shibutani K., Izawa M., Soma Y., Onodera K. A study on blood viscosity in CVA - the relationships between blood viscosity and duration after stroke, and the effects of pentoxifylline. Acta Neurol. Scand. 1979; 60: 622, Suppl. 72
   Google Scholar
• Meyer J. S., Welch K. M. Relationship of cerebral blood flow and metabolism to neurological symptoms. Prog. Brain Res. 1972; 35: 28552. Meyer J. S., Welch K. M. Relationship of cerebral blood flow and metabolism to neurological symptoms. Prog. Brain Res. 1972; 35: 285
   PubMedGoogle Scholar
• Meyer J. S., Ryu T., Toyoda M., Shinohara Y., Wiederholt J. K., Guirand B. Evidence for a Pasteur effect regulating cerebral oxygen and carbohydrate metabolism in man. Neurology 1969; 19: 65453. Meyer J. S., Ryu T., Toyoda M., Shinohara Y., Wiederholt J. K., Guirand B. Evidence for a Pasteur effect regulating cerebral oxygen and carbohydrate metabolism in man. Neurology 1969; 19: 654
   Google Scholar
• MÜLler R. Zum gegenwartigen Stand der Hämorheologie aus klinisch-pharmakologisher Sicht. Therapiewoche 1980; 30: 244054. MÜLler R. Zum gegenwartigen Stand der Hämorheologie aus klinisch-pharmakologisher Sicht. Therapiewoche 1980; 30: 2440
   Google Scholar
• MÜLler R., Lehrach F. Haemorheological role of platelet aggregation and hypercoagulability in microcirculation: therapeutical approach with pentoxifylline. Pharmatherapeutica 1980; 2: 37255. MÜLler R., Lehrach F. Haemorheological role of platelet aggregation and hypercoagulability in microcirculation: therapeutical approach with pentoxifylline. Pharmatherapeutica 1980; 2: 372
   PubMedGoogle Scholar
• MÜLler R., Schroer R. Cerebrovascular circulatory disorders: new impacts on pathophysiology and therapy. J. Med. 1979; 10: 34756. MÜLler R., Schroer R. Cerebrovascular circulatory disorders: new impacts on pathophysiology and therapy. J. Med. 1979; 10: 347
   PubMedGoogle Scholar
• De Oliveira R. S. P., De Miranda A. A. V. Estudo electroencefalografico e psicológico com BL 191 em patientes geronto-psiquiátrico. Rev. Bras. Med. 1977; 34: 6557. De Oliveira R. S. P., De Miranda A. A. V. Estudo electroencefalografico e psicológico com BL 191 em patientes geronto-psiquiátrico. Rev. Bras. Med. 1977; 34: 65
   Google Scholar
• Ott E., Bertha G., Marko P., Lechner H. Möglichkeiten und Grenzen der Behandlung zerebrovaskulärer Risikofaktoren. Der prakt. Arzt, 10 Kgr. Akad. Allg. Med. Graz 22–25 November, 1979; 197958. Ott E., Bertha G., Marko P., Lechner H. Möglichkeiten und Grenzen der Behandlung zerebrovaskulärer Risikofaktoren. Der prakt. Arzt, 10 Kgr. Akad. Allg. Med. Graz 22–25 November, 1979; 1979
   Google Scholar
• Parrot A. C., Hindmarch I. Arousal and performance - the ubiquitous inverted relationship. Comparison of changes in response latency and arousal level in normal subjects induced by CNS stimulants, sedatives and tranquillizers. I.R.C.S. (Med. Sci.) 1975; 3: 17659. Parrot A. C., Hindmarch I. Arousal and performance - the ubiquitous inverted relationship. Comparison of changes in response latency and arousal level in normal subjects induced by CNS stimulants, sedatives and tranquillizers. I.R.C.S. (Med. Sci.) 1975; 3: 176
   Google Scholar
• Pecker J., VailÉE B., Haranger J. M., Gueguen M. Torental et accidents ischémiques du systèmes nerveux central. Ouest Méd. 1978; 31: 157160. Pecker J., VailÉE B., Haranger J. M., Gueguen M. Torental et accidents ischémiques du systèmes nerveux central. Ouest Méd. 1978; 31: 1571
   Google Scholar
• Popendiker K., Boksay I., Bollmann V. Zur Pharmakologie des neuen peripheren Gefäŝdilatators 3,7-Dimeutyl-1-(5-oxo-hexyl)-xanthin. Arzneim. Forsch. 1971; 21: 116061. Popendiker K., Boksay I., Bollmann V. Zur Pharmakologie des neuen peripheren Gefäŝdilatators 3,7-Dimeutyl-1-(5-oxo-hexyl)-xanthin. Arzneim. Forsch. 1971; 21: 1160
   PubMedGoogle Scholar
• Porsche E., Stefanovich V., Grigoleit H.-G. Inhibition of K+-leakage from human red blood cells by pentoxifylline. I.R.C.S. (Med. Sci.) 1977; 5: 48462. Porsche E., Stefanovich V., Grigoleit H.-G. Inhibition of K+-leakage from human red blood cells by pentoxifylline. I.R.C.S. (Med. Sci.) 1977; 5: 484
   Google Scholar
• Pricladnitzki A. Emprego de una nova droga vasoactiva em pacientes geriatricos portadores de insufficifincia circulatoria cerebral. Rev. Bras. Med. 1979; 36: 30963. Pricladnitzki A. Emprego de una nova droga vasoactiva em pacientes geriatricos portadores de insufficifincia circulatoria cerebral. Rev. Bras. Med. 1979; 36: 309
   Google Scholar
• Rizzo G., Ariano R. Nuovi criteri terapeutici in corso di vasculopatie cerebrali croniche diffuse. Osservazioni cliniche in soggetti anziani. Policlinico 1979; 86: 14764. Rizzo G., Ariano R. Nuovi criteri terapeutici in corso di vasculopatie cerebrali croniche diffuse. Osservazioni cliniche in soggetti anziani. Policlinico 1979; 86: 147
   Google Scholar
• Satewachin I. I., Iljin V. N., Schestakov V. A., Alexandrova N. P., Rodinov S. V., Danilova L. M., Iljin S. G. The use of pentoxifylline in a combined regimen for the prevention of re-thrombosis in major blood vessels. Pharmatherapeutica 1978; 2: 109, Suppl. 165. Satewachin I. I., Iljin V. N., Schestakov V. A., Alexandrova N. P., Rodinov S. V., Danilova L. M., Iljin S. G. The use of pentoxifylline in a combined regimen for the prevention of re-thrombosis in major blood vessels. Pharmatherapeutica 1978; 2: 109, Suppl. 1
   Google Scholar
• Seiffge D. Methods for the investigation of drug-influence on aggregation and deformability of red blood cells (RBC). Conference on Haemorheology and Diseases. Nancy 17–19 October, 1979; 197966. Seiffge D. Methods for the investigation of drug-influence on aggregation and deformability of red blood cells (RBC). Conference on Haemorheology and Diseases. Nancy 17–19 October, 1979; 1979
   Google Scholar
• Seiffge D. Effect of pentoxifylline on red cell aggregation (RCA). I.R.C.S. 1980; 8: 72767. Seiffge D. Effect of pentoxifylline on red cell aggregation (RCA). I.R.C.S. 1980; 8: 727
   Google Scholar
• Sen S., Chakravarty A. Clinical experience with pentoxifylline in occlusive cerebrovascular disorders. Angiology 1977; 28: 34068. Sen S., Chakravarty A. Clinical experience with pentoxifylline in occlusive cerebrovascular disorders. Angiology 1977; 28: 340
   PubMed Web of Science ®Google Scholar
• Schmid-SchÖNbein H. Der gegenwärtige Stand der Hämorheologie: Methoden, Befunde und Bedeutung für die Physiologie und Pathologie des Blutkreislaufs. Wien. Klin. Wochenschr. 1978; 90: 24569. Schmid-SchÖNbein H. Der gegenwärtige Stand der Hämorheologie: Methoden, Befunde und Bedeutung für die Physiologie und Pathologie des Blutkreislaufs. Wien. Klin. Wochenschr. 1978; 90: 245
   PubMedGoogle Scholar
• Schmid-SchÖNbein H., Wells R. E. Rheological properties of human erythrocytes and their influence upon anomalous viscosity of blood. Ergeb. Physiol. 1971; 63: 14670. Schmid-SchÖNbein H., Wells R. E. Rheological properties of human erythrocytes and their influence upon anomalous viscosity of blood. Ergeb. Physiol. 1971; 63: 146
   PubMedGoogle Scholar
• Smud R., Sermukslis B., Kartin D. Changes in blood viscosity induced by pentoxifylline. Pharmatherapeutica 1976; 1: 22971. Smud R., Sermukslis B., Kartin D. Changes in blood viscosity induced by pentoxifylline. Pharmatherapeutica 1976; 1: 229
   Google Scholar
• Spriet A., Better D., Dechorgnat J., Simon P. Adherence of elderly patients to treatment with pentoxifylline. Clin. Pharmacol. Ther. 1980; 27: 172. Spriet A., Better D., Dechorgnat J., Simon P. Adherence of elderly patients to treatment with pentoxifylline. Clin. Pharmacol. Ther. 1980; 27: 1
   PubMed Web of Science ®Google Scholar
• Stefanovich V. Concerning specificity of the influence of pentoxifylline on various cyclic AMP phosphodiesterases. Res. Commun. Chem. Path. Pharmacol. 1974; 8: 64373. Stefanovich V. Concerning specificity of the influence of pentoxifylline on various cyclic AMP phosphodiesterases. Res. Commun. Chem. Path. Pharmacol. 1974; 8: 643
   Google Scholar
• Stefanovich V. Zum biochemischen Profil von Pentoxifyllin. Der prakt Arzt. Kgr. Bd. Pentoxifyllin Coll. Wien 27 November, 1975; 197574. Stefanovich V. Zum biochemischen Profil von Pentoxifyllin. Der prakt Arzt. Kgr. Bd. Pentoxifyllin Coll. Wien 27 November, 1975; 1975
   Google Scholar
• Stefanovich V., Jarvis P., Grigoleit H.-G. Effekt von Pentoxifyllin auf das zyklische AMP-System in Thrombozyten. Med. Welt 1975; 26: 223075. Stefanovich V., Jarvis P., Grigoleit H.-G. Effekt von Pentoxifyllin auf das zyklische AMP-System in Thrombozyten. Med. Welt 1975; 26: 2230
   PubMedGoogle Scholar
• Stefanovich V., Macukat M., Hunn G. Effect of pentoxifylline on brain adenine nucleotide levels in anoxic rats. I.R.C.S. (Med. Sci.) 1976; 4: 50676. Stefanovich V., Macukat M., Hunn G. Effect of pentoxifylline on brain adenine nucleotide levels in anoxic rats. I.R.C.S. (Med. Sci.) 1976; 4: 506
   Google Scholar
• StÖRmer B., Kleinschmidt F., Loose D., Kremer K. Rheological changes in the blood of patients with chronical arterial occlusive disease following administration of vasoactive drugs. Curr. Med. Res. Opin. 1977; 4: 58877. StÖRmer B., Kleinschmidt F., Loose D., Kremer K. Rheological changes in the blood of patients with chronical arterial occlusive disease following administration of vasoactive drugs. Curr. Med. Res. Opin. 1977; 4: 588
   PubMed Web of Science ®Google Scholar
• Takahashi Y. Red blood cell deformability in CVD patients. Paper presented at 3rd Gen. Meeting Jpn. Soc. Stroke. Akita 8–10 June, 197878. Takahashi Y. Red blood cell deformability in CVD patients. Paper presented at 3rd Gen. Meeting Jpn. Soc. Stroke. Akita 8–10 June, 1978
   Google Scholar
• Takamatsu S., Sato K., Takamatsu M., Sakuta S., Mizuno S. Changes in haematological and blood chemical parameters after treatment of aged arteriosclerotic patients with pentoxifylline. Pharmatherapeutica 1979; 2: 16579. Takamatsu S., Sato K., Takamatsu M., Sakuta S., Mizuno S. Changes in haematological and blood chemical parameters after treatment of aged arteriosclerotic patients with pentoxifylline. Pharmatherapeutica 1979; 2: 165
   Google Scholar
• Vetterlein F., Halfter R., Schmidt G. Regional blood flow determination in rats by the microsphere method during i.v. infusion of vasodilating agents. Arzneim. Forsch. 1979; 29: 74780. Vetterlein F., Halfter R., Schmidt G. Regional blood flow determination in rats by the microsphere method during i.v. infusion of vasodilating agents. Arzneim. Forsch. 1979; 29: 747
   PubMed Web of Science ®Google Scholar
• VÖLker D. Haemorheological investigations in patients with vascular disease undergoing treatment with pentoxifylline. Pharmatherapeutica 1976; 1: 15481. VÖLker D. Haemorheological investigations in patients with vascular disease undergoing treatment with pentoxifylline. Pharmatherapeutica 1976; 1: 154
   Google Scholar
• Weed R. J., La Celle P. L., Merrill E. W. Metabolic dependence of red cell deformability. J. Clin. Invest. 1969; 48: 79582. Weed R. J., La Celle P. L., Merrill E. W. Metabolic dependence of red cell deformability. J. Clin. Invest. 1969; 48: 795
   PubMed Web of Science ®Google Scholar
• Weithmann K. U. Pentoxifylline: its influence on interaction between blood vessel wall and platelets. I.R.C.S. (Med. Sci.) 1980; 8: 29383. Weithmann K. U. Pentoxifylline: its influence on interaction between blood vessel wall and platelets. I.R.C.S. (Med. Sci.) 1980; 8: 293
   Web of Science ®Google Scholar
• Wieck H. H. Zur Psychopathologie cerebrovaskulärer Prozesse. Internist 1975; 17: 184. Wieck H. H. Zur Psychopathologie cerebrovaskulärer Prozesse. Internist 1975; 17: 1
   Google Scholar
• Zinzadse K. I., Gulischwili L. N., Tavchelidse T. D., Vorobjov O. J. The effect of pentoxifylline on the flow properties of blood in experimental atherosclerosis in rabbits. Pharmatherapeutica 1978; 2: 118, Suppl. 185. Zinzadse K. I., Gulischwili L. N., Tavchelidse T. D., Vorobjov O. J. The effect of pentoxifylline on the flow properties of blood in experimental atherosclerosis in rabbits. Pharmatherapeutica 1978; 2: 118, Suppl. 1
   Google Scholar